Molecular Partners Ag (MOLN) Enterprise Value (QoQ) (2021 - 2026)
Molecular Partners Ag (MOLN) Enterprise Value (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -666.56% |
| Dec 31, 2025 | 89.96% |
| Sep 30, 2025 | -231.89% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | -52,954.76% |
| Dec 31, 2024 | 99.78% |
| Sep 30, 2024 | -43,474.30% |
| Jun 30, 2024 | 99.78% |
| Mar 31, 2024 | -37,064.42% |
| Dec 31, 2023 | 99.73% |
| Sep 30, 2023 | -31,810.78% |
| Jun 30, 2023 | 99.70% |
| Mar 31, 2023 | -30,806.92% |
| Dec 31, 2022 | 99.64% |
| Sep 30, 2022 | -24,284.72% |
| Jun 30, 2022 | 99.81% |
| Mar 31, 2022 | -106,664.67% |
| Dec 31, 2021 | 99.84% |
| Sep 30, 2021 | -64,954.37% |